1-7 of 7
Lian Li
Close
Sort by
Journal Articles

Analysis of Fluorescence in Situ Hybridization Detection Results and Clinical Indicators in 51 Patients with Multiple Myeloma

Mingyu Zhao, Longrong Ran, Xin Luo, Lian Li, Yu Peng, Shuang Chen, Wei Zhang, Zailin Yang
Journal: Blood
Blood (2022) 140 (Supplement 1): 12551.
https://doi.org/10.1182/blood-2022-166581
Published: 2022
Journal Articles

Clinical Value of Gene Copy Number Variation Detection in Peripheral Blood in the Diagnosis and Treatment of Lymphoma

Shuang Chen, Lian Li, Xin Luo, Wei Zhang, Zailin Yang
Journal: Blood
Blood (2022) 140 (Supplement 1): 12129.
https://doi.org/10.1182/blood-2022-165759
Published: 2022
Journal Articles

Drug-Free Macromolecular Therapeutics Induce Apoptosis in Cells Isolated from Patients with B Cell Malignancies with Enhanced Apoptosis Induction By Pretreatment with Gemcitabine

Jiawei Wang, Lian Li, PhD, Jiyuan Yang, PhD, Phillip M. Clair, MS, Martha Glenn, MD, Deborah M. Stephens, D. Christopher Radford, PhDCandidate, Ken M. Kosak, Michael W. Deininger, MD PhD, Paul J Shami, MD, Jindřich Kopeček, PhD
Journal: Blood
Blood (2018) 132 (Supplement 1): 4426.
https://doi.org/10.1182/blood-2018-99-112001
Published: 2018
Journal Articles

Predicting FIX Activity in Prophylaxis Patients Using Recombinant FIX Fc Fusion Protein for Treatment of Bleeding Episodes

Jerry S Powell, MD, Margareth Ozelo, MD PhD, Margaret V. Ragni, MD MPH, John Pasi, MBChB, PhD FRCP, FRCPath, David J. Perry, MD PhD FRCP, FRCPath, Ying Zhu, MPH, Baisong Mei, MD PhD, Glenn F Pierce, MD PhD, Lian Li, PhD, Brian Robinson, MD
Journal: Blood
Blood (2014) 124 (21): 2842.
https://doi.org/10.1182/blood.V124.21.2842.2842
Published: 2014
Journal Articles

Predicting FVIII Activity in Patients Who Use Recombinant FVIII Fc Fusion Protein for Prophylaxis and Treatment of Bleeding Episodes

Doris V. Quon, MD PhD, Johnny N. Mahlangu, MBBCh, MMed, FCPath, Amy D Shapiro, John Pasi, MBChB, PhD FRCP, FRCPath, Ying Zhu, MPH, Glenn F Pierce, MD PhD, Lian Li, PhD, Geoffrey Allen, MD
Journal: Blood
Blood (2014) 124 (21): 1522.
https://doi.org/10.1182/blood.V124.21.1522.1522
Published: 2014
Journal Articles

Safety and prolonged activity of recombinant factor VIII Fc fusion protein in hemophilia A patients

Clinical Trials & Observations
Jerry S. Powell, Neil C. Josephson, Doris Quon, Margaret V. Ragni, Gregory Cheng, Ella Li, Haiyan Jiang, Lian Li, Jennifer A. Dumont, Jaya Goyal, Xin Zhang, Jurg Sommer, Justin McCue, Margaret Barbetti, Alvin Luk, Glenn F. Pierce
Journal: Blood
Blood (2012) 119 (13): 3031–3037.
https://doi.org/10.1182/blood-2011-09-382846
Published: 2012
Includes: Supplemental data
Journal Articles

Recombinant factor IX-Fc fusion protein (rFIXFc) demonstrates safety and prolonged activity in a phase 1/2a study in hemophilia B patients

Clinical Trials & Observations
Amy D. Shapiro, Margaret V. Ragni, Leonard A. Valentino, Nigel S. Key, Neil C. Josephson, Jerry S. Powell, Gregory Cheng, Arthur R. Thompson, Jaya Goyal, Karen L. Tubridy, Robert T. Peters, Jennifer A. Dumont, Donald Euwart, Lian Li, Bengt Hallén, Peter Gozzi, Alan J. Bitonti, Haiyan Jiang, Alvin Luk, Glenn F. Pierce
Journal: Blood
Blood (2012) 119 (3): 666–672.
https://doi.org/10.1182/blood-2011-07-367003
Published: 2012
Includes: Supplemental data